ADRSupport Community  

Go Back   ADRSupport Community > General Discussion > Spinal Roundtable

Spinal Roundtable Discuss Humanitarian Exemption, definition in progress : fda.gov in the General Discussion forums; The term " humanitarian exemption " was read in a couple of places, ISSLS journal abstract(s), again recently the 2008 ...

English (US)  Español (ES)  Francais (FR)  Deutsches (DE) 

Reply
 
LinkBack Thread Tools
  #1  
Old 01-19-2009, 03:07 PM
Senior Member
 
Join Date: Aug 2007
Posts: 654
Default Humanitarian Exemption, definition in progress : fda.gov

The term "humanitarian exemption" was read in a couple of places, ISSLS journal abstract(s), again recently the 2008 NASS abstracts specifically regarding multi-level ADR , TDR TDA ( two (2) or more levels ). I am a layperson, not a medical professional, regulatory lawyer, blah blah ...

"Humanitarian exemption" may be defined in one of the documents below. More reading required. Excerpts from a an existing humanitarian exemption (Stryker Biotech OP-1) document follows LINK:
"As defined in the Federal Food, Drug,
and Cosmetic Act (21 CFR 814.124), the definition
of a Humanitarian Use Device (HUD) is a device
that is intended to benefit patients in the
treatment and diagnosis of diseases or conditions
that affect or is manifested in fewer than 4,000
individuals in the United States per year. "

FDA developed and published the Safe Medical Devices Act
on June 26, 1996 to provide an incentive that would
encourage innovative manufacturers, ... DEL.TEXT
development of devices that would benefit only a
small patient population each year. "
Started with FDA, CBER (Center for Biologics Evaluation and Research) looking for OP-1, rhBMP-7 reference to Intervertebral Disc, DegDiscDisease and www.clinicaltrials.gov . I worked backwards(?).

~~~~~~~~~~~~~~~~~~~~~~~

slackwater_sf
mva, 2-level lumbar surgical candidate
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #2  
Old 01-19-2009, 03:42 PM
Senior Member
 
Join Date: Aug 2007
Posts: 654
Default mildly related

Quote:
Originally Posted by Slackwater View Post
existing humanitarian exemption (Stryker Biotech OP-1) document follows (DEL.TEXT)

Started with FDA, CBER (Center for Biologics Evaluation and Research) looking for OP-1, rhBMP-7 reference to Intervertebral Disc, DegDiscDisease and www.clinicaltrials.gov .
Looking for the clinicaltrial.gov identifier on the OP-1 trial for DDD at a single-level, nothing is found to date. There is no magic wand here at this time. BMP-7 (also known as OP-1) stimulates proliferation and Extra Cellular Matrix biosynthesis in nucleus pulposus and annulus fibrosus cells. GDF-5 and TGF-β1 exhibit similar, differing anabolic effects. This is a long dialogue item that I am not qualified to continue.

Overexpression of growth factors and their receptors is a tissue response to disc wounding and degeneration, aimed at the restoration of tissue homeostasis. ProSpec, Protein Specialists, make "laboratory use" growth factors, ... Bone Morphogenic Proteins among other products.



~~~~~~~~~~~~~~~~~~~~~~~

slackwater_sf
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

Bookmarks

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are Off
Refbacks are On


Similar Threads
Thread Thread Starter Forum Replies Last Post
Progress on ADR costs in the US mmglobal Arthroplasty Central 2 04-24-2005 01:35 AM
Melody's Surgery Progress Melody Beattie Arthroplasty Central 8 04-16-2005 12:59 PM
Good progress report ReachtheSummit Arthroplasty Central 4 01-13-2005 07:54 AM
9 Weeks Post-op Progress Judy Arthroplasty Central 6 12-27-2004 03:20 AM


All times are GMT -4. The time now is 01:41 AM.


© Copyright 2006-2009 ADRSupport.org All rights reserved.

1 2 3 4 5 6 7 8 9 10 11 12 13